Lab21 Limited
184 Science Park
Milton Road
Cambridge CB4 0GA UK


Project leader

Dr Berwyn Clarke

Dr Berwyn Clarke

Phone: +44 1223 395461
Fax: +44 1223 395451

Project staff

Simon Scrimshaw

Phone: +44 1223 395479
Fax: +44 1223 395451

Institute presentation

About Lab21

Lab21 is a global provider of state-of-the-art diagnostic products and services, it supports blood bank screening, medical diagnostics and drug discovery. Lab21 customers include international healthcare providers, pharmaceutical and biotechnology companies.

The product division of the Company manufactures immunodiagnostic kits and reagents that are distributed into 110 international countries and is focused on infectious diseases for the blood-banking market.

The service division has a growing test portfolio providing companion diagnostics and high technology molecular assays for the growing integration of personalised medicine into healthcare. These services are currently in infectious diseases, oncology and pharmacogenetics areas with emerging interests in cardiovascular and metabolic disease.

Lab21's clinical reference laboratory and corporate office is based in Cambridge and has additional UK sites in Newmarket and Bridport. It also has operations in South Carolina, USA. The Company's investors include Merlin Biosciences, Nexus Medical Partners, Medicis Capital, Rowan Dartington and Kreos Capital.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.